Curanex Pharmaceuticals is a developmental-stage company focused on creating innovative botanical drugs for inflammatory diseases. Using our proprietary platform, we identify and optimize compounds from medicinal plants to develop therapies that address significant unmet medical needs. Our lead candidate, Phyto-N, is under investigation for its potential to treat a range of inflammatory conditions. We are committed to improving patients’ lives while building long-term value for our shareholders.